Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME; FaSTER Research Consortium. Lambert-Messerlian G, et al. Among authors: nyberg da. Am J Obstet Gynecol. 2008 Jul;199(1):62.e1-6. doi: 10.1016/j.ajog.2007.12.003. Am J Obstet Gynecol. 2008. PMID: 18585522 Free PMC article.
First- and second-trimester Down syndrome screening markers in pregnancies achieved through assisted reproductive technologies (ART): a FASTER trial study.
Lambert-Messerlian G, Dugoff L, Vidaver J, Canick JA, Malone FD, Ball RH, Comstock CH, Nyberg DA, Saade G, Eddleman K, Klugman S, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME. Lambert-Messerlian G, et al. Among authors: nyberg da. Prenat Diagn. 2006 Aug;26(8):672-8. doi: 10.1002/pd.1469. Prenat Diagn. 2006. PMID: 16764012 Clinical Trial.
Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers.
Dugoff L, Cuckle HS, Hobbins JC, Malone FD, Belfort MA, Nyberg DA, Comstock CH, Saade GR, Eddleman KA, Dar P, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; FaSTER Trial Research Consortium. Dugoff L, et al. Among authors: nyberg da. Am J Obstet Gynecol. 2008 Sep;199(3):290.e1-6. doi: 10.1016/j.ajog.2008.06.099. Am J Obstet Gynecol. 2008. PMID: 18771987
Role of second-trimester genetic sonography after Down syndrome screening.
Aagaard-Tillery KM, Malone FD, Nyberg DA, Porter TF, Cuckle HS, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Aagaard-Tillery KM, et al. Among authors: nyberg da. Obstet Gynecol. 2009 Dec;114(6):1189-1196. doi: 10.1097/AOG.0b013e3181c15064. Obstet Gynecol. 2009. PMID: 19935018 Free PMC article. Clinical Trial.
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery.
Haddow JE, Cleary-Goldman J, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME; First- and Second-Trimester Risk of Aneuploidy (FaSTER) Research Consortium. Haddow JE, et al. Among authors: nyberg da. Obstet Gynecol. 2010 Jul;116(1):58-62. doi: 10.1097/AOG.0b013e3181e10b30. Obstet Gynecol. 2010. PMID: 20567168
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption.
Haddow JE, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D'Alton ME; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium. Haddow JE, et al. Among authors: nyberg da. Obstet Gynecol. 2011 Feb;117(2 Pt 1):287-292. doi: 10.1097/AOG.0b013e31820513d9. Obstet Gynecol. 2011. PMID: 21252741
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, Ferreira J, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME; FASTER Research Consortium. Comstock CH, et al. Among authors: nyberg da. Am J Obstet Gynecol. 2006 Sep;195(3):843-7. doi: 10.1016/j.ajog.2006.06.006. Am J Obstet Gynecol. 2006. PMID: 16949423
Comparison of serum markers in first-trimester down syndrome screening.
Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveux LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowitz RL, Dar P, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Canick JA, et al. Among authors: nyberg da. Obstet Gynecol. 2006 Nov;108(5):1192-9. doi: 10.1097/01.AOG.0000241095.19638.f2. Obstet Gynecol. 2006. PMID: 17077242
First- and second-trimester evaluation of risk for Down syndrome.
Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Emig D, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Ball RH, et al. Among authors: nyberg da. Obstet Gynecol. 2007 Jul;110(1):10-7. doi: 10.1097/01.AOG.0000263470.89007.e3. Obstet Gynecol. 2007. PMID: 17601890
First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D'Alton ME; First and Second Trimester Evaluation of Risk (FASTER) Research Consortium. Breathnach FM, et al. Among authors: nyberg da. Obstet Gynecol. 2007 Sep;110(3):651-7. doi: 10.1097/01.AOG.0000278570.76392.a6. Obstet Gynecol. 2007. PMID: 17766613
146 results